 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Viking Therapeutics Inc. (VKTX)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2017-07-13 Sale | 2018-09-27 9:25 pm | Viking Therapeutics Inc. | VKTX | LIGAND PHARMACEUTICALS INC 10% Owner | 262,881 | $19.15 | $5,034,250 | 6,038,083 (Direct) | View |
| 2020-06-30 Sale | 2020-06-30 5:54 pm | Viking Therapeutics Inc. | VKTX | FOEHR MATTHEW W Director | 13,000 | $7.35 | $95,550 | 26,250 (Direct) | View |
| 2020-08-25 Sale | 2020-08-27 7:06 pm | Viking Therapeutics Inc. | VKTX | LIGAND PHARMACEUTICALS INC 10% Owner | 164,488 | $8.0716 | $1,327,684 | 5,819,383 (Direct) | View |
| 2020-08-25 Sale(A) | 2020-08-28 5:11 pm | Viking Therapeutics Inc. | VKTX | LIGAND PHARMACEUTICALS INC 10% Owner | 148,700 | $8.108 | $1,205,660 | 5,819,383 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2018-07-01 Option Award | 2018-07-03 5:25 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Masamune Hiroko Chief Development Officer | 15,000 | $0 | 42,000 (Direct) | View |
| 2018-07-01 Option Award | 2018-07-03 5:25 pm | 2019-07-01 2028-07-01 | Viking Therapeutics Inc. | VKTX | Masamune Hiroko Chief Development Officer | 42,000 | $9.49 | 42,000 (Direct) | View |
| 2017-07-13 Other | 2018-09-27 9:25 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | LIGAND PHARMACEUTICALS INC 10% Owner | 38,630 | $38,630 | 6,038,083 (Direct) | View |
| 2017-07-13 Other | 2018-09-27 9:25 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | LIGAND PHARMACEUTICALS INC 10% Owner | 1,916,509 | $1,916,509 | 6,038,083 (Direct) | View |
| 2019-01-02 Option Award | 2019-01-03 8:20 pm | 2020-01-02 2029-01-02 | Viking Therapeutics Inc. | VKTX | Rowland Charles A Jr Director | 22,000 | $8.32 | 22,000 (Direct) | View |
| 2019-01-02 Option Award | 2019-01-03 8:22 pm | 2020-01-02 2029-01-02 | Viking Therapeutics Inc. | VKTX | MACARTNEY LAWSON Director | 22,000 | $8.32 | 22,000 (Direct) | View |
| 2019-01-02 Option Award | 2019-01-03 8:26 pm | 2020-01-02 2029-01-02 | Viking Therapeutics Inc. | VKTX | FOEHR MATTHEW W Director | 22,000 | $8.32 | 22,000 (Direct) | View |
| 2019-01-02 Option Award | 2019-01-03 8:27 pm | 2020-01-02 2029-01-02 | Viking Therapeutics Inc. | VKTX | SINGLETON J MATTHEW Director | 22,000 | $8.32 | 22,000 (Direct) | View |
| 2019-01-02 Option Award | 2019-01-03 8:28 pm | 2020-01-02 2029-01-02 | Viking Therapeutics Inc. | VKTX | Webster Stephen W Director | 22,000 | $8.32 | 22,000 (Direct) | View |
| 2019-01-03 Option Award | 2019-01-03 8:31 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian CEO | 80,897 | $0 | 235,554 (Direct) | View |
| 2019-01-03 Option Award | 2019-01-03 8:31 pm | 2020-01-03 2029-01-03 | Viking Therapeutics Inc. | VKTX | Lian Brian CEO | 235,554 | $7.58 | 235,554 (Direct) | View |
| 2019-01-03 Option Award | 2019-01-03 8:33 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Masamune Hiroko Chief Development Officer | 22,667 | $0 | 66,000 (Direct) | View |
| 2019-01-03 Option Award | 2019-01-03 8:33 pm | 2020-01-03 2029-01-03 | Viking Therapeutics Inc. | VKTX | Masamune Hiroko Chief Development Officer | 66,000 | $7.58 | 66,000 (Direct) | View |
| 2019-01-03 Option Award | 2019-01-03 8:35 pm | 2020-01-03 2029-01-03 | Viking Therapeutics Inc. | VKTX | MORNEAU MICHAEL VP | 29,000 | $7.58 | 29,000 (Direct) | View |
| 2019-01-19 Tax Withholding | 2019-01-22 7:13 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian CEO | 4,333 | $8.78 | 1,560,152 (Direct) | View |
| 2019-01-19 Tax Withholding | 2019-01-22 7:13 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | MORNEAU MICHAEL VP | 2,044 | $8.78 | 91,991 (Direct) | View |
| 2019-07-01 Option Award | 2019-07-02 4:20 pm | 2020-07-01 2029-07-01 | Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director | 55,000 | $8.32 | 55,000 (Direct) | View |
| 2019-07-31 Option Award | 2019-08-02 5:59 pm | 2020-07-31 2029-07-31 | Viking Therapeutics Inc. | VKTX | MORNEAU MICHAEL VP | 7,500 | $7.69 | 7,500 (Direct) | View |
| 2019-10-31 Option Award | 2019-10-31 6:27 pm | 2020-10-31 2029-10-31 | Viking Therapeutics Inc. | VKTX | MORNEAU MICHAEL VP | 2,500 | $6.47 | 2,500 (Direct) | View |
| 2020-01-02 Option Award | 2020-01-03 7:54 pm | 2021-01-02 2030-01-02 | Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director | 22,000 | $7.95 | 22,000 (Direct) | View |
| 2020-01-02 Option Award | 2020-01-03 7:55 pm | 2021-01-02 2030-01-02 | Viking Therapeutics Inc. | VKTX | Rowland Charles A Jr Director | 22,000 | $7.95 | 22,000 (Direct) | View |
| 2020-01-02 Option Award | 2020-01-03 7:57 pm | 2021-01-02 2030-01-02 | Viking Therapeutics Inc. | VKTX | MACARTNEY LAWSON Director | 22,000 | $7.95 | 22,000 (Direct) | View |
| 2020-01-02 Option Award | 2020-01-03 7:59 pm | 2021-01-02 2030-01-02 | Viking Therapeutics Inc. | VKTX | FOEHR MATTHEW W Director | 22,000 | $7.95 | 22,000 (Direct) | View |
| 2020-01-02 Option Award | 2020-01-03 7:59 pm | 2021-01-02 2030-01-02 | Viking Therapeutics Inc. | VKTX | SINGLETON J MATTHEW Director | 22,000 | $7.95 | 22,000 (Direct) | View |
| 2020-01-02 Option Award | 2020-01-03 8:01 pm | 2021-01-02 2030-01-02 | Viking Therapeutics Inc. | VKTX | Webster Stephen W Director | 22,000 | $7.95 | 22,000 (Direct) | View |
| 2020-01-03 Option Award | 2020-01-03 8:01 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian CEO | 153,333 | $0 | 345,000 (Direct) | View |
| 2020-01-03 Tax Withholding | 2020-01-03 8:01 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian CEO | 6,782 | $7.77 | 345,000 (Direct) | View |
| 2020-01-03 Option Award | 2020-01-03 8:01 pm | 2021-01-03 2030-01-03 | Viking Therapeutics Inc. | VKTX | Lian Brian CEO | 345,000 | $7.77 | 345,000 (Direct) | View |
| 2020-01-03 Option Award | 2020-01-03 8:03 pm | 2021-01-03 2030-01-03 | Viking Therapeutics Inc. | VKTX | MORNEAU MICHAEL VP | 40,000 | $7.77 | 40,000 (Direct) | View |
| 2020-01-19 Tax Withholding | 2020-01-21 5:35 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | MORNEAU MICHAEL VP | 2,044 | $7.18 | 92,840 (Direct) | View |
| 2020-01-19 Tax Withholding | 2020-01-21 5:39 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian CEO | 3,195 | $7.18 | 1,704,312 (Direct) | View |
| 2020-03-31 Option Award | 2020-04-03 5:47 pm | 2021-03-31 2030-03-31 | Viking Therapeutics Inc. | VKTX | MORNEAU MICHAEL VP | 15,000 | $4.68 | 15,000 (Direct) | View |
| 2020-09-15 Option Award | 2020-09-16 5:18 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian CEO | 55,500 | $0 | 1,742,363 (Direct) | View |
| 2020-09-15 Tax Withholding | 2020-09-16 5:18 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian CEO | 19,192 | $6.25 | 1,742,363 (Direct) | View |
| 2020-09-15 Option Award | 2020-09-16 5:21 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | MORNEAU MICHAEL VP | 4,500 | $0 | 97,873 (Direct) | View |
| 2020-09-15 Tax Withholding | 2020-09-16 5:21 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | MORNEAU MICHAEL VP | 1,557 | $6.25 | 97,873 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 4:26 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna COO | 73,000 | $0 | 90,000 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 4:26 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna COO | 6,750 | $0 | 90,000 (Direct) | View |
| 2021-01-04 Tax Withholding | 2021-01-06 4:26 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna COO | 2,773 | $5.8 | 90,000 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 4:26 pm | 2022-01-04 2031-01-04 | Viking Therapeutics Inc. | VKTX | Mancini Marianna COO | 90,000 | $5.8 | 90,000 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 4:28 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG CFO | 64,667 | $0 | 78,000 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 4:28 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG CFO | 6,783 | $0 | 78,000 (Direct) | View |
| 2021-01-04 Tax Withholding | 2021-01-06 4:28 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG CFO | 2,787 | $5.8 | 78,000 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 4:28 pm | 2022-01-04 2031-01-04 | Viking Therapeutics Inc. | VKTX | ZANTE GREG CFO | 78,000 | $5.8 | 78,000 (Direct) | View |
| 2021-01-03 Tax Withholding | 2021-01-06 4:34 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian CEO | 31,545 | $5.63 | 369,000 (Direct) | View |
| 2021-01-03 Option Award | 2021-01-06 4:34 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian CEO | 164,000 | $0 | 369,000 (Direct) | View |
| 2021-01-03 Option Award | 2021-01-06 4:34 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian CEO | 40,333 | $0 | 369,000 (Direct) | View |
| 2021-01-03 Tax Withholding | 2021-01-06 4:34 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian CEO | 16,973 | $5.8 | 369,000 (Direct) | View |
| 2021-01-03 Option Award | 2021-01-06 4:34 pm | 2022-01-04 2031-01-04 | Viking Therapeutics Inc. | VKTX | Lian Brian CEO | 369,000 | $5.8 | 369,000 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 4:37 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | MORNEAU MICHAEL VP | 14,667 | $0 | 33,000 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 4:37 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | MORNEAU MICHAEL VP | 6,667 | $0 | 33,000 (Direct) | View |
| 2021-01-04 Tax Withholding | 2021-01-06 4:37 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | MORNEAU MICHAEL VP | 2,739 | $5.8 | 33,000 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 4:37 pm | 2022-01-04 2031-01-04 | Viking Therapeutics Inc. | VKTX | MORNEAU MICHAEL VP | 33,000 | $5.8 | 33,000 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 4:38 pm | 2022-01-04 2031-01-04 | Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director | 22,000 | $5.8 | 22,000 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 4:39 pm | 2022-01-04 2031-01-04 | Viking Therapeutics Inc. | VKTX | SINGLETON J MATTHEW Director | 22,000 | $5.8 | 22,000 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 4:40 pm | 2022-01-04 2031-01-04 | Viking Therapeutics Inc. | VKTX | FOEHR MATTHEW W Director | 22,000 | $5.8 | 22,000 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 4:41 pm | 2022-01-04 2031-01-04 | Viking Therapeutics Inc. | VKTX | MACARTNEY LAWSON Director | 22,000 | $5.8 | 22,000 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 4:42 pm | 2022-01-04 2031-01-04 | Viking Therapeutics Inc. | VKTX | Rowland Charles A Jr Director | 22,000 | $5.8 | 22,000 (Direct) | View |